Drug Protocol Reduces Risk of HIV Infection

An anti-HIV drug combination, Truvada, plus prevention strategies can reduce the risk of healthy adolescents at risk for acquiring HIV. The Food and Drug Administration has approved the drug combination for HIV prevention treatment for adolescents 15 years and older. 

The research for this pre-exposure prophylaxis, or PrEP, was supported by Westat. Westat provided full-service support for this study through the Adolescent Trials Network for HIV/AIDS Interventions (ATN) – ATN  protocol 113.  The Eunice Kennedy Shriver National Institute of Child Health and Human Development funds ATN research.

Learn more about Westat’s work supporting ATN.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
Client List
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
ClearWay Minnesota
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Denver
University of Maryland Baltimore Campus
University of Michigan

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity, or any other protected status under applicable law. Notices to Employees & Applicants.